Congenital Heart Disease (CHD) Global Market Report 2025

Global Congenital Heart Disease (CHD) Market Report 2024

Congenital Heart Disease (CHD) Global Market Report 2025 – By Type (Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types), By Diagnosis (Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis), By Treatment (Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications), By Age Group (Infants, Children, Adolescents, Adults), By Application (Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions) – Market Size, Trends, And Global Forecast 2025-2034

Name: Congenital Heart Disease (CHD) Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Congenital Heart Disease (CHD) Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Congenital Heart Disease (CHD) Global Market Report 2025

Proud Members Of

Congenital Heart Disease (CHD) Market Definition

Congenital heart disease (CHD) refers to a range of birth defects affecting the structure and function of the heart that are present at birth. These defects can involve the walls of the heart, the valves of the heart, and the arteries and veins near the heart. The treatment for CHD depends on the type and severity of the defect and may include medications, catheter-based interventions, open-heart surgery, or heart transplantation.

The main types of congenital heart disease (CHD) are heart valve defects, heart wall defects, blood vessel defects, and others. Heart valve defects refer to abnormalities or malfunctions in the heart valves, which regulate blood flow through the heart. They can be diagnosed by electrocardiogram, chest X-ray, echocardiogram, transesophageal echocardiogram, pulse oximetry, exercise stress test, Cardiac computed tomography (CT) scan or magnetic resonance imaging (MRI), cardiac catheterization, other diagnosis and treatment include interventional cardiology, cardiac surgery, Telemedicine, Medication Management, and lifestyle modifications. The age groups include infants, children, adolescents, and adults, who are treated in hospitals and clinics, diagnostic centers, ambulatory surgical centers, research and academic institutions applications.

Congenital Heart Disease (CHD) Market Segmentation

The congenital heart disease (CHD) market covered in this report is segmented –

1) By Type: Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types

2) By Diagnosis: Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis

3) By Treatment: Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications

4) By Age Group: Infants, Children, Adolescents, Adults

5) By Application: Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions

Subsegments:

1) By Heart Valve Defects: Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation

2) By Heart Wall Defects: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF)

3) By Blood Vessel Defects: Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus

4) By Other Types: Single Ventricle Defects, Ebstein’s Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction

Congenital Heart Disease (CHD) Market Size and growth rate 2025 to 2029: Graph

Congenital Heart Disease (CHD) Market Size 2025 And Growth Rate

The congenital heart disease (CHD) market size has grown rapidly in recent years. It will grow from $4.42 billion in 2024 to $4.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the increased prevalence of risk factors such as obesity and smoking, improved diagnostic technologies, expanded geriatric population, heightened awareness campaigns, enhanced reimbursement policies, and increased investment in research and development.

Congenital Heart Disease (CHD) Market Growth Forecast

The congenital heart disease (CHD) market size is expected to see strong growth in the next few years. It will grow to $7.05 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to expanding access to healthcare services in developing regions, continuous innovation in cardiac imaging technologies, growing awareness campaigns promoting early detection and treatment, rising healthcare expenditure globally, and the development of personalized medicine. Major trends in the forecast period include adoption of minimally invasive surgical techniques, expanding use of telemedicine for remote patient monitoring and consultations, rising demand for personalized treatment approaches, development of innovative implantable devices with enhanced functionality and longevity, integration of artificial intelligence and machine learning in diagnostic and therapeutic processes.

Book your 30 minutes free consultation with our research experts

Congenital Heart Disease (CHD) Market Driver: Maternal Diabetes Driving Congenital Heart Disease Market Growth

The increase in maternal diabetes cases is expected to propel the growth of the congenital heart disease (CHD) market going forward. Maternal diabetes, or gestational diabetes mellitus (GDM), refers to diabetes that arises during pregnancy in women who did not have diabetes before conception. Maternal diabetes is caused by changes in lifestyle, including sedentary behavior and unhealthy dietary habits, and an overall rise in obesity rates among women of childbearing age. Maternal diabetes can lead to congenital heart disease (CHD) in infants due to the high blood sugar levels affecting fetal heart development. The elevated glucose levels in the mother's blood can disrupt the normal development of the baby's heart, increasing the risk of CHD. For instance, in October 2023, according to the National Health Service a UK-based government department, adverse pregnancy outcomes in women diagnosed with type 2 diabetes in 2021 was 4.9% which increased to 6.6% in 2022. Therefore, the increase in maternal diabetes cases is driving the growth of the congenital heart disease (CHD) market.

Global Congenital Heart Disease (CHD) Market Major Players

Major companies operating in the congenital heart disease (CHD) market are Pfizer Inc., AstraZeneca Plc, Abbott Laboratories, Novartis AG, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Neusoft Corp., Carestream Health, Midmark Corporation, Contec Medical Systems, Randox Laboratories Ltd., Schiller AG, BPL Medical Technologies, Compumedics Limited, Biocare Medical, Bionet America Inc., Nasan Medical Electronics Pvt Ltd

Global Congenital Heart Disease (CHD) Market Trend: Innovative Non-Surgical Heart Valves Transforming Congenital Heart Disease Treatment

Major companies operating in the congenital heart disease market are developing non-surgical heart valves to improve patient outcomes and quality of life. Non-surgical heart valves, or transcatheter, are medical devices that treat heart valve diseases without needing traditional open-heart surgery. For instance, in February 2023, Medtronic, a US-based medical technology company, reintroduced its Harmony Transcatheter Pulmonary Valve (TPV) System. It is a groundbreaking, minimally invasive alternative to open-heart surgery for patients with congenital heart disease, specifically those with native or surgically repaired right ventricular outflow tract (RVOT) anomalies. This system is the first FDA-approved valve designed for the right side, providing a non-surgical solution for patients with severe pulmonary valve regurgitation. The Harmony TPV System received U.S. FDA approval in 2021. It was reintroduced following a voluntary recall, demonstrating Medtronic's commitment to advancing solutions for congenital heart disease patients.

Congenital Heart Disease (CHD) Market Merger And Acquisition: Novartis And AC Health Partner To Combat Cancer And Heart Disease In The Philippines

In May 2024, Novartis Healthcare Private Limited, a Switzerland-based pharmaceutical company partnered with Ayala Healthcare Holdings, Inc. (AC Health) and launched an Integrated Cardiovascular and Cancer Care. This partnership that aims to broaden access to innovative medicines for breast cancer, heart failure, and high cholesterol. Ayala Healthcare Holdings, Inc. (AC Health) is a Philippines-based pharma company focused on generic drugs.

Regional Outlook For The Global Congenital Heart Disease (CHD) Market

North America was the largest region in the congenital heart disease (CHD) market in 2024. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart disease (CHD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Congenital Heart Disease (CHD) Market?

The congenital heart disease (CHD) market consists of revenues earned by entities by providing services such as medical consultations, diagnostic tests, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The congenital heart disease (CHD) market also includes sales of cardiac implants such as pacemakers, implantable cardioverter-defibrillators (ICDs), and ventricular assist devices (VADs). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Congenital Heart Disease (CHD) Industry?

The congenital heart disease market research report is one of a series of new reports from The Business Research Company that provides congenital heart disease market statistics, including congenital heart disease industry global market size, regional shares, competitors with a congenital heart disease market share, detailed congenital heart disease market segments, market trends and opportunities, and any further data you may need to thrive in the congenital heart disease industry. This congenital heart disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Congenital Heart Disease (CHD) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.87 billion
Revenue Forecast In 2034	$7.05 billion
Growth Rate	CAGR of 9.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types 2) By Diagnosis: Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis 3) By Treatment: Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications 4) By Age Group: Infants, Children, Adolescents, Adults 5) By Application: Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions Subsegments: 1) By Heart Valve Defects: Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation 2) By Heart Wall Defects: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF) 3) By Blood Vessel Defects: Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus 4) By Other Types: Single Ventricle Defects, Ebstein’s Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., AstraZeneca Plc, Abbott Laboratories, Novartis AG, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Neusoft Corp., Carestream Health, Midmark Corporation, Contec Medical Systems, Randox Laboratories Ltd., Schiller AG, BPL Medical Technologies, Compumedics Limited, Biocare Medical, Bionet America Inc., Nasan Medical Electronics Pvt Ltd
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Congenital Heart Disease (CHD) Market Characteristics

3. Congenital Heart Disease (CHD) Market Trends And Strategies

4. Congenital Heart Disease (CHD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Congenital Heart Disease (CHD) Growth Analysis And Strategic Analysis Framework

5.1. Global Congenital Heart Disease (CHD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Congenital Heart Disease (CHD) Market Growth Rate Analysis

5.4. Global Congenital Heart Disease (CHD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Congenital Heart Disease (CHD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Congenital Heart Disease (CHD) Total Addressable Market (TAM)

6. Congenital Heart Disease (CHD) Market Segmentation

6.1. Global Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Heart Valve Defects

Heart Wall Defects

Blood Vessel Defects

Other Types

6.2. Global Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Electrocardiogram

Chest X-ray

Echocardiogram

Transesophageal Echocardiogram

Pulse Oximetry

Exercise Stress Test

Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI)

Cardiac Catheterization

Other Diagnosis

6.3. Global Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Interventional Cardiology

Cardiac Surgery

Telemedicine

Medication Management

Lifestyle Modifications

6.4. Global Congenital Heart Disease (CHD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infants

Children

Adolescents

Adults

6.5. Global Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostic Centers

Ambulatory Surgical Centers

Research And Academic Institutions

6.6. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Valve Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Aortic Valve Stenosis

Pulmonary Valve Stenosis

Mitral Valve Prolapse

Tricuspid Valve Defects

Valve Regurgitation

6.7. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Wall Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Atrial Septal Defect (ASD)

Ventricular Septal Defect (VSD)

Atrioventricular Septal Defect (AVSD)

Hypoplastic Left Heart Syndrome (HLHS)

Tetralogy of Fallot (TOF)

6.8. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Blood Vessel Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Coarctation Of The Aorta

Patent Ductus Arteriosus (PDA)

Pulmonary Artery Stenosis

Transposition Of The Great Arteries (TGA)

Truncus Arteriosus

6.9. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single Ventricle Defects

Ebstein’s Anomaly

Total Anomalous Pulmonary Venous Return (TAPVR)

Coronary Artery Anomalies

Pulmonary Venous Obstruction

7. Congenital Heart Disease (CHD) Market Regional And Country Analysis

7.1. Global Congenital Heart Disease (CHD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Congenital Heart Disease (CHD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congenital Heart Disease (CHD) Market

8.1. Asia-Pacific Congenital Heart Disease (CHD) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congenital Heart Disease (CHD) Market

9.1. China Congenital Heart Disease (CHD) Market Overview

9.2. China Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congenital Heart Disease (CHD) Market

10.1. India Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congenital Heart Disease (CHD) Market

11.1. Japan Congenital Heart Disease (CHD) Market Overview

11.2. Japan Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congenital Heart Disease (CHD) Market

12.1. Australia Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congenital Heart Disease (CHD) Market

13.1. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congenital Heart Disease (CHD) Market

14.1. South Korea Congenital Heart Disease (CHD) Market Overview

14.2. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congenital Heart Disease (CHD) Market

15.1. Western Europe Congenital Heart Disease (CHD) Market Overview

15.2. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congenital Heart Disease (CHD) Market

16.1. UK Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congenital Heart Disease (CHD) Market

17.1. Germany Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congenital Heart Disease (CHD) Market

18.1. France Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congenital Heart Disease (CHD) Market

19.1. Italy Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congenital Heart Disease (CHD) Market

20.1. Spain Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congenital Heart Disease (CHD) Market

21.1. Eastern Europe Congenital Heart Disease (CHD) Market Overview

21.2. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congenital Heart Disease (CHD) Market

22.1. Russia Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congenital Heart Disease (CHD) Market

23.1. North America Congenital Heart Disease (CHD) Market Overview

23.2. North America Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congenital Heart Disease (CHD) Market

24.1. USA Congenital Heart Disease (CHD) Market Overview

24.2. USA Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congenital Heart Disease (CHD) Market

25.1. Canada Congenital Heart Disease (CHD) Market Overview

25.2. Canada Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congenital Heart Disease (CHD) Market

26.1. South America Congenital Heart Disease (CHD) Market Overview

26.2. South America Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congenital Heart Disease (CHD) Market

27.1. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congenital Heart Disease (CHD) Market

28.1. Middle East Congenital Heart Disease (CHD) Market Overview

28.2. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congenital Heart Disease (CHD) Market

29.1. Africa Congenital Heart Disease (CHD) Market Overview

29.2. Africa Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congenital Heart Disease (CHD) Market Competitive Landscape And Company Profiles

30.1. Congenital Heart Disease (CHD) Market Competitive Landscape

30.2. Congenital Heart Disease (CHD) Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Medtronic Overview, Products and Services, Strategy and Financial Analysis

31. Congenital Heart Disease (CHD) Market Other Major And Innovative Companies

31.1. Siemens Healthineers

31.2. Philips Healthcare

31.3. Roche Diagnostics International Ltd.

31.4. Boston Scientific Corp.

31.5. Laboratory Corporation of America Holdings (LabCorp)

31.6. Terumo Corporation

31.7. Mindray Medical International Limited

31.8. Canon Medical Systems Corporation

31.9. Masimo Corporation

31.10. Neusoft Corp.

31.11. Carestream Health

31.12. Midmark Corporation

31.13. Contec Medical Systems

31.14. Randox Laboratories Ltd.

31.15. Schiller AG

32. Global Congenital Heart Disease (CHD) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congenital Heart Disease (CHD) Market

34. Recent Developments In The Congenital Heart Disease (CHD) Market

35. Congenital Heart Disease (CHD) Market High Potential Countries, Segments and Strategies

35.1 Congenital Heart Disease (CHD) Market In 2029 - Countries Offering Most New Opportunities

35.2 Congenital Heart Disease (CHD) Market In 2029 - Segments Offering Most New Opportunities

35.3 Congenital Heart Disease (CHD) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Congenital Heart Disease (CHD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Valve Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Wall Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Blood Vessel Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Congenital Heart Disease (CHD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Congenital Heart Disease (CHD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: AstraZeneca Plc Financial Performance

Table 82: Abbott Laboratories Financial Performance

Table 83: Novartis AG Financial Performance

Table 84: Medtronic Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Congenital Heart Disease (CHD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Valve Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Wall Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Blood Vessel Defects, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Congenital Heart Disease (CHD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Congenital Heart Disease (CHD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: AstraZeneca Plc Financial Performance

Figure 82: Abbott Laboratories Financial Performance

Figure 83: Novartis AG Financial Performance

Figure 84: Medtronic Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Cardiovascular Ultrasound Global Market Report 2025 – By Type (Transthoracic Echocardiography, Transesophageal Echocardiography, Fetal Echocardiography, Other Types), By Technology (2D, 3D Or 4D, Doppler), By Display (Black Or White (B/W), Color), By End-Use (Hospital, Diagnostic Centers, Ambulatory Care Centers, Other End-Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiovascular Surgery Devices And Equipment Global Market Report 2025 – By Product Type (Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables), By Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications), By End User (Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research laboratories) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025 – By Product Type (Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems, Holter Monitoring Systems), By Type (Heart Disease, Coronary Heart Disease), By End-Use (Hospitals/Physician Clinic (Continuous Glucose Monitors), Home/Emergency, Research and Development (Clinical Trials, Universities, CRO)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiovascular Medical Lasers Global Market Report 2025 – By Type (Excimer Laser, Carbon Dioxide Laser), By Application (Laser Vascular Anastomosis, Transmyocardial Laser Revascularization, Laser Angioplasty For Peripheral Arterial Diseases), By End Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiovascular Implants Global Market Report 2025 – By Product (Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent), By Material (Metals and Alloys, Polymers, Biological Materials), By Application (Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications), By End-Users (Hospitals, Ambulatory Surgical Centers, Cardiac Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiovascular Digital Solutions Global Market Report 2025 – By Components (Devices, Software), By Services (Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs, Other Services), By Deployment (Cloud-Based, On-Premise), By End-Use (Hospitals and Clinics, Ambulatory Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiovascular Devices Global Market Report 2025 – By Type (Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiovascular And Soft Tissue Repair Patches Global Market Report 2025 – By Raw Materials (ePTFE, Biomaterial And Tissue-Engineered Material, Other Raw Materials ), By Product (Synthetic Patch, Biologic Patch), By Application (Cardiac Repair, Atrial Septal Defect, Common Atrium, Defects Of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy Of Fallot, Right Ventricular Outflow Tract Reconstruction, Suture Bleeding, Vascular Repair And Reconstruction, Transposition Of The Great Vessels ), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Congenital Heart Disease (CHD) market?

How will the Congenital Heart Disease (CHD) market drivers and restraints affect the market dynamics? What forces will shape the Congenital Heart Disease (CHD) industry going forward?

The Congenital Heart Disease (CHD) market major growth driver - Maternal Diabetes Driving Congenital Heart Disease Market Growth. For further insights on the Congenital Heart Disease (CHD) market, request a sample here

What is the forecast market size or the forecast market value of the Congenital Heart Disease (CHD) market?

The Congenital Heart Disease (CHD) market size has grown strongly in recent years. The congenital heart disease (CHD) market size has grown rapidly in recent years. It will grow from $4.42 billion in 2024 to $4.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the increased prevalence of risk factors such as obesity and smoking, improved diagnostic technologies, expanded geriatric population, heightened awareness campaigns, enhanced reimbursement policies, and increased investment in research and development. The congenital heart disease (CHD) market size is expected to see strong growth in the next few years. It will grow to $7.05 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to expanding access to healthcare services in developing regions, continuous innovation in cardiac imaging technologies, growing awareness campaigns promoting early detection and treatment, rising healthcare expenditure globally, and the development of personalized medicine. Major trends in the forecast period include adoption of minimally invasive surgical techniques, expanding use of telemedicine for remote patient monitoring and consultations, rising demand for personalized treatment approaches, development of innovative implantable devices with enhanced functionality and longevity, integration of artificial intelligence and machine learning in diagnostic and therapeutic processes. For further insights on the Congenital Heart Disease (CHD) market, request a sample here

How is the Congenital Heart Disease (CHD) market segmented?

The congenital heart disease (CHD) market covered in this report is segmented –
1) By Type: Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types
2) By Diagnosis: Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis
3) By Treatment: Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications
4) By Age Group: Infants, Children, Adolescents, Adults
5) By Application: Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions
Subsegments:
1) By Heart Valve Defects: Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation
2) By Heart Wall Defects: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF)
3) By Blood Vessel Defects: Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus
4) By Other Types: Single Ventricle Defects, Ebstein’s Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction For further insights on the Congenital Heart Disease (CHD) market, request a sample here

Which region has the largest share of the Congenital Heart Disease (CHD) market? What are the other regions covered in the report?

North America was the largest region in the congenital heart disease (CHD) market in 2023. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Congenital Heart Disease (CHD) market, request a sample here.

Who are the major players in the Congenital Heart Disease (CHD) market?

What are the key trends in the Congenital Heart Disease (CHD) market?

Major trends in the Congenital Heart Disease (CHD) market include Innovative Non-Surgical Heart Valves Transforming Congenital Heart Disease Treatment. For further insights on the Congenital Heart Disease (CHD) market, request a sample here.

What are the major opportunities in the Congenital Heart Disease (CHD) market? What are the strategies for the Congenital Heart Disease (CHD) market?

For detailed insights on the major opportunities and strategies in the Congenital Heart Disease (CHD) market, request a sample here.

How does the Congenital Heart Disease (CHD) market relate to the overall economy and other similar markets?

For detailed insights on Congenital Heart Disease (CHD)'s relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Congenital Heart Disease (CHD) industry?

For detailed insights on the mergers and acquisitions in the Congenital Heart Disease (CHD) industry, request a sample here.

What are the key dynamics influencing the Congenital Heart Disease (CHD) market growth? SWOT analysis of the Congenital Heart Disease (CHD) market.

For detailed insights on the key dynamics influencing the Congenital Heart Disease (CHD) market growth and SWOT analysis of the Congenital Heart Disease (CHD) industry, request a sample here.